About My Health Careers Internship MedBlogs Contact us

Africa’s HIV Volunteers Warned About Possible Increased Risk of HIV

by Medindia Content Team on October 26, 2007 at 3:18 PM
Font : A-A+

Africa’s HIV Volunteers Warned About Possible Increased Risk of HIV

HIV/AIDS researchers in South Africa on Tuesday began warning 801 volunteers who participated in a trial of Merck's experimental HIV vaccine about a possible increased risk of HIV, the Washington Post reports.

Merck last month announced that it had ended its Phase II trial, which began in late 2004 and involved 3,000 HIV-negative volunteers, after its experimental vaccine failed to prevent HIV infection in participants or prove effective in delaying the progression of the virus to AIDS.


The trial was stopped by the Data and Safety Monitoring Board, an independent overseer. Some researchers have theorized that because HIV-positive people who have stronger CD4+ T-cell responses tend to fight the virus better, a vaccine that simulated a T-cell response might be able to control HIV/AIDS. The Merck vaccine was made from a weakened version of a common cold virus that served as a mode for providing three synthetically produced genes from HIV, known as gag, pol and nef.

The Merck Phase II trials largely involved volunteers in the U.S. and Latin America, and those trials were overseen by a U.S. ethics board. The South African trials began this year and had their own, separate oversight board, the Post reports. Researchers in Soweto, Cape Town, Durban and two other sites in South Africa began contacting the trial volunteers primarily by cell phone text messages with the goal of "unblinding" the trial, or telling each volunteer whether they received the vaccine or a placebo, according to the Post.

Researchers said that the vaccine will not cause infection with HIV but could cause changes in the immune system that might make HIV transmission easier during later exposure to the virus. Researchers plan to tell the roughly 50% of volunteers who received the vaccine that they might have an increased risk of contracting HIV.

According to Mark Feinberg, Merck's vice president for medical affairs, the U.S. ethics oversight board has not decided if it will tell volunteers in the U.S. and Latin America whether they received the vaccine or a placebo. Feinberg said that continuing research could be compromised if volunteers are told whether they received the vaccine or a placebo. He added that volunteers who request that information will be told.

In addition, researchers are counseling all trial volunteers that the vaccine might lead to a possible increased risk of HIV. "Given the complexity of the issue, we feel the best conclusions will be reached when all the data are analyzed in their entirety," Feinberg said. Vaccine researchers are scheduled to meet in Seattle on Nov. 7 to discuss the trial, the Post reports.

Source: Kaiser Family Foundation

News A-Z
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Oral Health And AIDS AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Prostitution: Fresh Stakes in the Oldest Trade HIV Symptom 

Recommended Reading
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV...
Merck’s AIDS Vaccine Fails, Trials Halted
An AIDS vaccine trial has been halted by its manufacturers, the Merck, when some volunteers become ....
Shortage of Doctors and Nurses Affects AIDS Treatment in Africa
AIDS continues to explode the African continent. But there is a woeful shortage of doctors and ......
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV...
"AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure...
AIDS/HIV - Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical Features...
AIDS/HIV - Epidemiology
AIDS or HIV is an epidemic disease, a potentially deadly infection that can be prevented with preca...
AIDS/HIV - Health Education
Encyclopedia section of medindia gives general info about AIDS information and health education....
Oral Health And AIDS
AIDS has taken on massive proportions in modern times. It is estimated that over 15 million people a...
Prostitution: Fresh Stakes in the Oldest Trade
Prostitution has broadened its base to include street prostitution, massage brothels, gigolo outcall...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use